200 related articles for article (PubMed ID: 24662801)
1. Intensified chemo-immunotherapy with or without stem cell transplantation in newly diagnosed patients with peripheral T-cell lymphoma.
Corradini P; Vitolo U; Rambaldi A; Miceli R; Patriarca F; Gallamini A; Olivieri A; Benedetti F; Todeschini G; Rossi G; Salvi F; Bruno B; Baldini L; Ferreri A; Patti C; Tarella C; Pileri S; Dodero A
Leukemia; 2014 Sep; 28(9):1885-91. PubMed ID: 24662801
[TBL] [Abstract][Full Text] [Related]
2. Up-front autologous stem-cell transplantation in peripheral T-cell lymphoma: NLG-T-01.
d'Amore F; Relander T; Lauritzsen GF; Jantunen E; Hagberg H; Anderson H; Holte H; Österborg A; Merup M; Brown P; Kuittinen O; Erlanson M; Østenstad B; Fagerli UM; Gadeberg OV; Sundström C; Delabie J; Ralfkiaer E; Vornanen M; Toldbod HE
J Clin Oncol; 2012 Sep; 30(25):3093-9. PubMed ID: 22851556
[TBL] [Abstract][Full Text] [Related]
3. The impact of stem cell transplantation on the natural course of peripheral T-cell lymphoma: a real-world experience.
Rohlfing S; Dietrich S; Witzens-Harig M; Hegenbart U; Schönland S; Luft T; Ho AD; Dreger P
Ann Hematol; 2018 Jul; 97(7):1241-1250. PubMed ID: 29549411
[TBL] [Abstract][Full Text] [Related]
4. First-line therapy of peripheral T-cell lymphoma: extension and long-term follow-up of a study investigating the role of autologous stem cell transplantation.
Wilhelm M; Smetak M; Reimer P; Geissinger E; Ruediger T; Metzner B; Schmitz N; Engert A; Schaefer-Eckart K; Birkmann J
Blood Cancer J; 2016 Jul; 6(7):e452. PubMed ID: 27471868
[TBL] [Abstract][Full Text] [Related]
5. Allogeneic stem cell transplantation for peripheral T cell lymphomas: a retrospective study in 285 patients from the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC).
Mamez AC; Dupont A; Blaise D; Chevallier P; Forcade E; Ceballos P; Mohty M; Suarez F; Beguin Y; Peffault De Latour R; Rubio MT; Tournilhac O; Nguyen S
J Hematol Oncol; 2020 May; 13(1):56. PubMed ID: 32429979
[TBL] [Abstract][Full Text] [Related]
6. A randomized phase 3 trial of autologous vs allogeneic transplantation as part of first-line therapy in poor-risk peripheral T-NHL.
Schmitz N; Truemper L; Bouabdallah K; Ziepert M; Leclerc M; Cartron G; Jaccard A; Reimer P; Wagner E; Wilhelm M; Sanhes L; Lamy T; de Leval L; Rosenwald A; Roussel M; Kroschinsky F; Lindemann W; Dreger P; Viardot A; Milpied N; Gisselbrecht C; Wulf G; Gyan E; Gaulard P; Bay JO; Glass B; Poeschel V; Damaj G; Sibon D; Delmer A; Bilger K; Banos A; Haenel M; Dreyling M; Metzner B; Keller U; Braulke F; Friedrichs B; Nickelsen M; Altmann B; Tournilhac O
Blood; 2021 May; 137(19):2646-2656. PubMed ID: 33512419
[TBL] [Abstract][Full Text] [Related]
7. First-line therapy for T cell lymphomas: a retrospective population-based analysis of 906 T cell lymphoma patients.
Janikova A; Chloupkova R; Campr V; Klener P; Hamouzova J; Belada D; Prochazka V; Pytlik R; Pirnos J; Duras J; Mocikova H; Bortlicek Z; Kopalova N; Mayer J; Trneny M
Ann Hematol; 2019 Aug; 98(8):1961-1972. PubMed ID: 31065733
[TBL] [Abstract][Full Text] [Related]
8. Upfront allogeneic stem-cell transplantation for patients with nonlocalized untreated peripheral T-cell lymphoma: an intention-to-treat analysis from a single center.
Loirat M; Chevallier P; Leux C; Moreau A; Bossard C; Guillaume T; Gastinne T; Delaunay J; Blin N; Mahé B; Dubruille V; Augeul-Meunier K; Peterlin P; Maisonneuve H; Moreau P; Juge-Morineau N; Jardel H; Mohty M; Moreau P; Le Gouill S
Ann Oncol; 2015 Feb; 26(2):386-92. PubMed ID: 25392158
[TBL] [Abstract][Full Text] [Related]
9. [A comparative study of induction chemotherapy with or without autologous hematopoietic stem cell transplantation in the treatment of newly diagnosed young medium/high risk diffuse large B cell lymphoma patients].
Wang X; Xia B; Wang CY; Li MZ; Xu W; Yuan T; Tian C; Zhao HF; Yang HL; Zhao ZG; Wang XF; Wang YF; Yu Y; Zhang YZ
Zhonghua Xue Ye Xue Za Zhi; 2019 Feb; 40(2):117-124. PubMed ID: 30831626
[No Abstract] [Full Text] [Related]
10. Prolonged survival of patients with peripheral T-cell lymphoma after first-line intensive sequential chemotherapy with autologous stem cell transplantation.
Prochazka V; Faber E; Raida L; Vondrakova J; Kucerova L; Jarosova M; Indrak K; Papajik T
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2009 Mar; 153(1):63-6. PubMed ID: 19365529
[TBL] [Abstract][Full Text] [Related]
11. Allogeneic transplantation following a reduced-intensity conditioning regimen in relapsed/refractory peripheral T-cell lymphomas: long-term remissions and response to donor lymphocyte infusions support the role of a graft-versus-lymphoma effect.
Dodero A; Spina F; Narni F; Patriarca F; Cavattoni I; Benedetti F; Ciceri F; Baronciani D; Scimè R; Pogliani E; Rambaldi A; Bonifazi F; Dalto S; Bruno B; Corradini P
Leukemia; 2012 Mar; 26(3):520-6. PubMed ID: 21904377
[TBL] [Abstract][Full Text] [Related]
12. Autologous stem cell transplantation as frontline strategy for peripheral T-cell lymphoma: A single-centre experience.
Han X; Zhang W; Zhou D; Ruan J; Duan M; Zhu T; Li J; Cai H; Cao X; Ouyang M
J Int Med Res; 2017 Feb; 45(1):290-302. PubMed ID: 28222648
[TBL] [Abstract][Full Text] [Related]
13. Peripheral T-cell lymphoma: the role of hematopoietic stem cell transplantation.
Gkotzamanidou M; Papadimitriou CA
Crit Rev Oncol Hematol; 2014 Feb; 89(2):248-61. PubMed ID: 24075060
[TBL] [Abstract][Full Text] [Related]
14. [Follicular lymphoma: first - line selection criteria of treatment].
Nesterova ES; Kravchenko SK; Kovrigina AM; Gemdzhian EG; Plastinina LV; Babaeva FE; Obukhova TN; Magomedova AU; Gaponova TV; Kremenetskaya AM; Vorobyev AI
Ter Arkh; 2019 Aug; 91(8):75-83. PubMed ID: 32598757
[TBL] [Abstract][Full Text] [Related]
15. Prognosis of patients with peripheral T cell lymphoma who achieve complete response after CHOP/CHOP-like chemotherapy without autologous stem cell transplantation as an initial treatment.
Kitahara H; Maruyama D; Maeshima AM; Makita S; Miyamoto KI; Fukuhara S; Munakata W; Suzuki T; Kobayashi Y; Tajima K; Terauchi T; Kurihara H; Taniguchi H; Komatsu N; Tobinai K
Ann Hematol; 2017 Mar; 96(3):411-420. PubMed ID: 27928587
[TBL] [Abstract][Full Text] [Related]
16. Long-term outcome of patients with peripheral T-cell lymphoma treated with first-line intensive chemotherapy followed by autologous stem cell transplantation.
Prochazka V; Faber E; Raida L; Papajik T; Vondrakova J; Rusinakova Z; Kucerova L; Myslivecek M; Indrak K
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2011 Mar; 155(1):63-9. PubMed ID: 21475380
[TBL] [Abstract][Full Text] [Related]
17. Hematopoietic Cell Transplantation and Adoptive Cell Therapy in Peripheral T Cell Lymphoma.
Rogers AM; Brammer JE
Curr Hematol Malig Rep; 2020 Aug; 15(4):316-332. PubMed ID: 32529515
[TBL] [Abstract][Full Text] [Related]
18. Intensive chemotherapy (high-dose CHOP/ESHAP regimen) followed by autologous stem-cell transplantation in previously untreated patients with peripheral T-cell lymphoma.
Mercadal S; Briones J; Xicoy B; Pedro C; Escoda L; Estany C; Camós M; Colomo L; Espinosa I; Martínez S; Ribera JM; Martino R; Gutiérrez-García G; Montserrat E; López-Guillermo A;
Ann Oncol; 2008 May; 19(5):958-63. PubMed ID: 18303032
[TBL] [Abstract][Full Text] [Related]
19. High-dose therapy and autologous stem cell transplantation in peripheral T-cell lymphoma: treatment outcome and prognostic factor analysis.
Gui L; Shi YK; He XH; Lei YH; Zhang HZ; Han XH; Zhou SY; Liu P; Yang JL; Dong M; Zhang CG; Yang S; Qin Y
Int J Hematol; 2014 Jan; 99(1):69-78. PubMed ID: 24258711
[TBL] [Abstract][Full Text] [Related]
20. Autologous stem cell transplantation in first complete remission may not extend progression-free survival in patients with peripheral T cell lymphomas.
Yam C; Landsburg DJ; Nead KT; Lin X; Mato AR; Svoboda J; Loren AW; Frey NV; Stadtmauer EA; Porter DL; Schuster SJ; Nasta SD
Am J Hematol; 2016 Jul; 91(7):672-6. PubMed ID: 27012928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
